|
1
|
Ferlay J, Ervik M, Lam F, Colombet M, Mery
L, Piñeros M, Znaor A, Soerjomataram I and Bray F: Global Cancer
Observatory: Cancer Today. International Agency for Research on
Cancer; Lyon: 2020, https://gco.iarc.fr/today. Accessed December 20,
2022.
|
|
2
|
Waters JK and Reznik SI: Update on
management of squamous cell esophageal cancer. Curr Oncol Rep.
24:375–385. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arnold M, Ferlay J, van Berge Henegouwen
MI and Soerjomataram I: Global burden of oesophageal and gastric
cancer by histology and subsite in 2018. Gut. 69:1564–1571. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fitzmaurice C, Abate D, Abbasi N,
Abbastabar H, Abd-Allah F, Abdel-Rahman O, Abdelalim A, Abdoli A,
Abdollahpour I, Abdulle ASM, et al: Global, regional, and national
cancer incidence, mortality, years of life lost, years lived with
disability, and disability-adjusted life-years for 29 cancer
groups, 1990 to 2017: A systematic analysis for the global burden
of disease study. JAMA Oncol. 5:1749–1768. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pan R, Zhu M, Yu C, Lv J, Guo Y, Bian Z,
Yang L, Chen Y, Hu Z, Chen Z, et al: Cancer incidence and
mortality: A cohort study in China, 2008-2013. Int J Cancer.
141:1315–1323. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lagergren J, Smyth E, Cunningham D and
Lagergren P: Oesophageal cancer. Lancet. 390:2383–2396. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zeng H, Chen W, Zheng R, Zhang S, Ji JS,
Zou X, Xia C, Sun K, Yang Z, Li H, et al: Changing cancer survival
in China during 2003-15: : A pooled analysis of 17 population-based
cancer registries. Lancet Glob Health. 6:e555–e567. 2018.
View Article : Google Scholar
|
|
9
|
Lin DC, Hao JJ, Nagata Y, Xu L, Shang L,
Meng X, Sato Y, Okuno Y, Varela AM, Ding LM, et al: Genomic and
molecular characterization of esophageal squamous cell carcinoma.
Nat Genet. 46:467–473. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu C, Wang Z, Song X, Feng XS, Abnet CC,
He J, Hu N, Zuo XB, Tan W, Zhan Q, et al: Joint analysis of three
genome-wide association studies of esophageal squamous cell
carcinoma in Chinese populations. Nat Genet. 46:1001–1006. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang S, Guo Y, Li Z, Zhang Y, Zhou T, You
W, Pan K and Li W: A systematic review of metabolomic profiling of
gastric cancer and esophageal cancer. Cancer Biol Med. 17:181–198.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen X, Kang R, Kroemer G and Tang D:
Broadening horizons: The role of ferroptosis in cancer. Nat Rev
Clin Oncol. 18:280–296. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu J, Ren L, Li S, Li W, Zheng X, Yang Y,
Fu W, Yi J, Wang J and Du G: The biology, function, and
applications of exosomes in cancer. Acta Pharm Sin B. 11:2783–2797.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen X, Zhou Z, Zhang Z, Zhao C, Li J,
Jiang J, Huang B and Qin Y: Puerarin inhibits EMT induced by
oxaliplatin via targeting carbonic anhydrase XII. Front Pharmacol.
13:9694222022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang WS, SriRamaratnam R, Welsch ME,
Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji
AF, Clish CB, et al: Regulation of ferroptotic cancer cell death by
GPX4. Cell. 156:317–331. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang L, Kon N, Li T, Wang SJ, Su T,
Hibshoosh H, Baer R and Gu W: Ferroptosis as a p53-mediated
activity during tumour suppression. Nature. 520:57–62. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Torti SV, Manz DH, Paul BT,
Blanchette-Farra N and Torti FM: Iron and cancer. Annu Rev Nutr.
38:97–125. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen X, Yu C, Kang R and Tang D: Iron
metabolism in ferroptosis. Front Cell Dev Biol. 8:5902262020.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stockwell BR, Angeli JP, Bayir H, Bush AI,
Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK, Kagan VE, et al:
Ferroptosis: A regulated cell death nexus linking metabolism, redox
biology, and disease. Cell. 171:273–285. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang WS, Kim KJ, Gaschler MM, Patel M,
Shchepinov MS and Stockwell BR: Peroxidation of polyunsaturated
fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci
USA. 113:E4966–E4975. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feng L, Zhao K, Sun L, Yin X, Zhang J, Liu
C and Li B: SLC7A11 regulated by NRF2 modulates esophageal squamous
cell carcinoma radiosensitivity by inhibiting ferroptosis. J Transl
Med. 19:3672021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cao JY and Dixon SJ: Mechanisms of
ferroptosis. Cell Mol Life Sci. 73:2195–2209. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Linkermann A, Skouta R, Himmerkus N, Mulay
SR, Dewitz C, De Zen F, Prokai A, Zuchtriegel G, Krombach F, Welz
PS, et al: Synchronized renal tubular cell death involves
ferroptosis. Proc Natl Acad Sci USA. 111:16836–16841. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Doll S, Proneth B, Tyurina YY, Panzilius
E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A,
et al: ACSL4 dictates ferroptosis sensitivity by shaping cellular
lipid composition. Nat Chem Biol. 13:91–98. 2017. View Article : Google Scholar :
|
|
26
|
Kenny EM, Fidan E, Yang Q, Anthonymuthu
TS, New LA, Meyer EA, Wang H, Kochanek PM, Dixon CE, Kagan VE and
Bayir H: Ferroptosis contributes to neuronal death and functional
outcome after traumatic brain injury. Crit Care Med. 47:410–418.
2019. View Article : Google Scholar :
|
|
27
|
Zhong W, Sun B, Gao W, Qin Y, Zhang H,
Huai L, Tang Y, Liang Y, He L, Zhang X, et al: Salvianolic acid A
targeting the transgelin-actin complex to enhance vasoconstriction.
EBioMedicine. 37:246–258. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wen F, Sun X, Sun C, Dong Z, Jia G, Bao W,
Yu H and Yang C: TAGLN is downregulated by TRAF6-mediated
proteasomal degradation in prostate cancer cells. Mol Cancer Res.
19:1113–1122. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xi Y, Liu J and Shen G: Low expression of
IGFBP4 and TAGLN accelerate the poor overall survival of
osteosarcoma. Sci Rep. 12:92982022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sayar N, Karahan G, Konu O, Bozkurt B,
Bozdogan O and Yulug IG: Transgelin gene is frequently
downregulated by promoter DNA hypermethylation in breast cancer.
Clin Epigenetics. 7:1042015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu B, Chen X, Li J, Qu Y, Su L, Peng Y,
Huang J, Yan J, Yu Y, Gu Q, et al: Stromal fibroblasts in the
microenvironment of gastric carcinomas promote tumor metastasis via
upregulating TAGLN expression. BMC Cell Biol. 14:172013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu X, Dong L, Zhang R, Ying K and Shen H:
Transgelin overexpression in lung adenocarcinoma is associated with
tumor progression. Int J Mol Med. 34:585–591. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou L, Zhang R, Zhang L, Sun Y, Yao W,
Zhao A, Li J and Yuan Y: Upregulation of transgelin is an
independent factor predictive of poor prognosis in patients with
advanced pancreatic cancer. Cancer Sci. 104:423–430. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhong W, Hou H, Liu T, Su S, Xi X, Liao Y,
Xie R, Jin G, Liu X, Zhu L, et al: Cartilage oligomeric matrix
protein promotes epithelial-mesenchymal transition by interacting
with Transgelin in colorectal cancer. Theranostics. 10:8790–8806.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang B, Chen Q, Wan C, Sun S, Zhu L, Zhao
Z, Zhong W and Wang B: Transgelin inhibits the malignant
progression of esophageal squamous cell carcinomas by regulating
epithelialmesenchymal transition. Front Oncol. 11:7094862021.
View Article : Google Scholar
|
|
36
|
Rice TW, Kelsen D, Blackstone EH, Ishwaran
H and Hofstetter WL: Esophagus and Esophagogastric Junction.
2017.AJCC Cancer Staging Manual. View Article : Google Scholar
|
|
37
|
Nicchia GP, Stigliano C, Sparaneo A, Rossi
A, Frigeri A and Svelto M: Inhibition of aquaporin-1 dependent
angiogenesis impairs tumour growth in a mouse model of melanoma. J
Mol Med (Berl). 91:613–623. 2013. View Article : Google Scholar
|
|
38
|
Simone L, Gargano CD, Pisani F, Cibelli A,
Mola MG, Frigeri A, Svelto M and Nicchia GP: Aquaporin-1 inhibition
reduces metastatic formation in a mouse model of melanoma. J Cell
Mol Med. 22:904–912. 2018.
|
|
39
|
Boren T, Xiong Y, Hakam A, Wenham R, Apte
S, Wei Z, Kamath S, Chen DT, Dressman H and Lancaster JM: MicroRNAs
and their target messenger RNAs associated with endometrial
carcinogenesis. Gynecol Oncol. 110:206–215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Najafi M, Farhood B and Mortezaee K:
Extracellular matrix (ECM) stiffness and degradation as cancer
drivers. J Cell Biochem. 120:2782–2790. 2019. View Article : Google Scholar
|
|
41
|
Murphy JM, Rodriguez Y, Jeong K, Ahn EE
and Lim SS: Targeting focal adhesion kinase in cancer cells and the
tumor microenvironment. Exp Mol Med. 52:877–886. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Abnet CC, Arnold M and Wei WQ:
Epidemiology of esophageal squamous cell carcinoma.
Gastroenterology. 154:360–373. 2018. View Article : Google Scholar
|
|
43
|
Lees-Miller JP, Heeley DH and Smillie LB:
An abundant and novel protein of 22 kDa (SM22) is widely
distributed in smooth muscles. Purification from bovine aorta.
Biochem J. 244:705–709. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Camoretti-Mercado B, Forsythe SM, LeBeau
MM, Espinosa R III, Vieira JE, Halayko AJ, Willadsen S, Kurtz B,
Ober C, Evans GA, et al: Expression and cytogenetic localization of
the human SM22 gene (TAGLN). Genomics. 49:452–457. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lawson D, Harrison M and Shapland C:
Fibroblast transgelin and smooth muscle SM22alpha are the same
protein, the expression of which is down-regulated in many cell
lines. Cell Motil Cytoskeleton. 38:250–257. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ueda T, Araki N, Mano M, Myoui A, Joyama
S, Ishiguro S, Yamamura H, Takahashi K, Kudawara I and Yoshikawa H:
Frequent expression of smooth muscle markers in malignant fibrous
histiocytoma of bone. J Clin Pathol. 55:853–858. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gimona M, Kaverina I, Resch GP, Vignal E
and Burgstaller G: Calponin repeats regulate actin filament
stability and formation of podosomes in smooth muscle cells. Mol
Biol Cell. 14:2482–2491. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wei X, Lou H, Zhou D, Jia Y, Li H, Huang
Q, Ma J, Yang Z, Sun C, Meng Y, et al: TAGLN mediated
stiffness-regulated ovarian cancer progression via RhoA/ROCK
pathway. J Exp Clin Cancer Res. 40:2922021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rao D, Kimler BF, Nothnick WB, Davis MK,
Fan F and Tawfik O: Transgelin: A potentially useful diagnostic
marker differentially expressed in triple-negative and
non-triple-negative breast cancers. Hum Pathol. 46:876–883. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Assinder SJ, Stanton JA and Prasad PD:
Transgelin: An actin-binding protein and tumour suppressor. Int J
Biochem Cell Biol. 41:482–486. 2009. View Article : Google Scholar
|
|
51
|
Thompson O, Moghraby JS, Ayscough KR and
Winder SJ: Depletion of the actin bundling protein SM22/transgelin
increases actin dynamics and enhances the tumourigenic phenotypes
of cells. BMC Cell Biol. 13:12012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yang Z, Chang YJ, Miyamoto H, Ni J, Niu Y,
Chen Z, Chen YL, Yao JL, di Sant'Agnese PA and Chang C: Transgelin
functions as a suppressor via inhibition of ARA54-enhanced androgen
receptor transactivation and prostate cancer cell growth. Mol
Endocrinol. 21:343–358. 2007. View Article : Google Scholar
|
|
53
|
Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao
N, Sun B and Wang G: Ferroptosis: Past, present and future. Cell
Death Dis. 11:882020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Li Y, Zeng X, Lu D, Yin M, Shan M and Gao
Y: Erastin induces ferroptosis via ferroportin-mediated iron
accumulation in endometriosis. Hum Reprod. 36:951–964. 2021.
View Article : Google Scholar
|
|
55
|
Tsui KH, Lin YH, Chang KS, Hou CP, Chen
PJ, Feng TH and Juang HH: Transgelin, a p53 and PTEN-upregulated
gene, inhibits the cell proliferation and invasion of human bladder
carcinoma cells in vitro and in vivo. Int J Mol Sci. 20:49462019.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhang ZW, Yang ZM, Zheng YC and Chen ZD:
Transgelin induces apoptosis of human prostate LNCaP cells through
its interaction with p53. Asian J Androl. 12:186–195. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Tang D and Kroemer G: Ferroptosis. Curr
Biol. 30:R1292–R1297. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Lei G, Zhuang L and Gan B: Targeting
ferroptosis as a vulnerability in cancer. Nat Rev Cancer.
22:381–396. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Liu MR, Zhu WT and Pei DS: System Xc(-): A
key regulatory target of ferroptosis in cancer. Invest New Drugs.
39:1123–1131. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Koppula P, Zhuang L and Gan B: Cystine
transporter SLC7A11/xCT in cancer: Ferroptosis, nutrient
dependency, and cancer therapy. Protein Cell. 12:599–620. 2021.
View Article : Google Scholar :
|
|
61
|
Gong D, Chen M, Wang Y, Shi J and Hou Y:
Role of ferroptosis on tumor progression and immunotherapy. Cell
Death Discov. 8:4272022. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zhou Y, Bian S, Zhou X, Cui Y, Wang W, Wen
L, Guo L, Fu W and Tang F: Single-cell multiomics sequencing
reveals prevalent genomic alterations in tumor stromal cells of
human colorectal cancer. Cancer Cell. 38:818–828.e5. 2020.
View Article : Google Scholar : PubMed/NCBI
|
